| |
|
|
|
Xtalks, Online
2025-11-21
In today’s rapidly evolving clinical research landscape, sponsors and CROs seek technology-enabled solutions to simplify study execution, enhance data quality and oversight and encourage patient engagement. This webinar demonstrates how Clinical ink combines configurable eCOA software and integrated digital health technologies (DHTs), enabling faster study development and robust real-world data collection. Clinical ink’s solutions offer a unified experience across multiple DHTs, reducing patient burden and ensuring high-quality data collection.
Attendees will learn how Clinical ink’s eCOA platform integrates with leading DHTs, such as continuous glucose monitors (CGMs), blood glucose meters (BGMs), smart weight and body composition scales and wearable physiological data capture devices, to streamline physiological data collection alongside patient-reported outcomes.
By minimizing technical barriers, Clinical ink empowers study teams to deploy technology-enhanced protocols efficiently. Clinical ink’s platform supports near-real-time data flow, providing a comprehensive view of the patient journey. The featured speakers will share real-world examples of how integrated DHTs have improved data capture, protocol adherence and reduced site and patient burden. The webinar will also cover regulatory considerations for risk assessment and data validation strategies to ensure reliable and compliant sensor-derived data within eCOA workflows.
Register for this webinar to learn how to enhance cardiometabolic trials using configurable eCOA and digital health technologies.
Keywords: Cardiovascular Device, Clinical Data, Clinical Research, Clinical Trials, CRO, Data Collection, Digital Health Technology, Drug Development, eCOA, Metabolic Disease, Other Software, Patient-Reported Outcomes, Therapeutic Areas
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Nicholas Alp, MD, PhD, FACC, Chief Medical Officer, Clinical ink
Steve Polyak, PhD, SVP, Head of Global Product Innovation, Clinical ink
Bill Barrasso, MBA, Chief Compliance Officer, Clinical ink
Jennifer Guild, MBA, PMP, Vice President of Strategic Partnerships and Cardiometabolic Operations, Clinical ink
(Moderator) Jessica Ryter, MBA, Sr. Director, Product Strategy, Clinical ink
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-11-21
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|